tiprankstipranks
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
US Market
NAMS
NewAmsterdam Pharma Company
RESEARCH TOOLSreports

NewAmsterdam Pharma Company (NAMS) Cash flow

249 Followers

NewAmsterdam Pharma Company Cash Flow

NAMS's free cash flow for Q4 2025 was $-40.98M. For the 2025 fiscal year, NAMS's free cash flow was decreased by $11.21M and operating cash flow was $-40.88M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Mar 23Dec 21
Operating Cash Flow
$ -147.78M$ -158.56M$ -141.22M$ 10.66M$ -29.51M
Investing Cash Flow
$ -174.92M$ -62.85M$ -24.00K$ -221.00K$ -24.00K
Financing Cash Flow
$ 29.52M$ 659.51M$ 8.91M$ 391.90M$ 84.70M
End Cash Position
$ 491.32M$ 771.74M$ 340.45M$ 467.73M$ 60.13M
Free Cash Flow
$ -148.03M$ -159.24M$ -141.24M$ 10.44M$ -29.54M
Currency in USD

NewAmsterdam Pharma Company Cash Flow